yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47351169-18FAC95E-F2AF-4645-89FF-DD01B9B4F168
Q47351169-18FAC95E-F2AF-4645-89FF-DD01B9B4F168
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47351169-18FAC95E-F2AF-4645-89FF-DD01B9B4F168
Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors.
P2860
Q47351169-18FAC95E-F2AF-4645-89FF-DD01B9B4F168
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47351169-18FAC95E-F2AF-4645-89FF-DD01B9B4F168
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f50d2b5e022f50f3f06d0bef8317e3fe7317cdc
P2860
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.